This article (2017) presents a case study of a physician who attempted to self-medicate with DMT in order to treat their bipolar depression (BD). However, the paper goes beyond the case study to discuss DMT in general terms, as well.
Abstract
“N,N-dimethyltryptamine (DMT) is a psychoactive substance that has been gaining popularity in therapeutic and recreational use. This is a case of a physician who chronically took DMT augmented with phenelzine in an attempt to self-medicate refractory bipolar depression. His presentation of altered mental status, mania, and psychosis is examined in regards to his DMT use. This case discusses DMT, the possible uses of DMT, and the theorized mechanism of DMT in psychosis and treatment of depression, particularly involving its agonist activity at 5-HT1A, 5-HT2A, and 5-HT2C. It is also important to recognize the dangers of self-medication, particularly amongst physicians.”
Authors: Tanida Brown, Wanda Shao, Shehzad Ayub, David Chong & Christian Cornelius
Summary of A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)
Introduction
DMT is a chemical compound found in plants such as Psychotria viridis and is used by South American shamans to produce ayahuasca, a psychedelic drink. It has been used to treat depression and addiction, but the effects of chronic use are unclear.
Case report
Find this paper
A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)
https://doi.org/10.1080/02791072.2017.1344898
Paywall | Google Scholar | Backup | 🕊
Study details
Compounds studied
DMT
Topics studied
Bipolar Disorder
Depression
Study characteristics
Case Study
Participants
1